Analytical Overview: Terns Pharmaceuticals Inc (TERN)’s Ratios Tell a Financial Story

Ulysses Smith

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

As of close of business last night, Terns Pharmaceuticals Inc’s stock clocked out at $34.33, down -4.56% from its previous closing price of $35.97. In other words, the price has decreased by -$4.56 from its previous closing price. On the day, 2.17 million shares were traded. TERN stock price reached its highest trading level at $36.46 during the session, while it also had its lowest trading level at $34.26.

Ratios:

To gain a deeper understanding of TERN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.52 and its Current Ratio is at 19.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On October 15, 2025, Truist started tracking the stock assigning a Buy rating and target price of $20.Truist initiated its Buy rating on October 15, 2025, with a $20 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 15 ’26 when Burroughs Amy L. sold 68,749 shares for $37.07 per share. The transaction valued at 2,548,603 led to the insider holds 288,976 shares of the business.

AMY BURROUGHS bought 97,915 shares of TERN for $3,640,480 on Jan 15 ’26. On Jan 05 ’26, another insider, Burroughs Amy L., who serves as the Chief Executive Officer of the company, sold 71,339 shares for $38.10 each. As a result, the insider received 2,718,230 and left with 138,976 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 3733980928 and an Enterprise Value of 2797832960.

Stock Price History:

The Beta on a monthly basis for TERN is -0.28, which has changed by 6.5783663 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $48.26, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is -1.28%, while the 200-Day Moving Average is calculated to be 161.71%.

Shares Statistics:

It appears that TERN traded 4.11M shares on average per day over the past three months and 2313850 shares per day over the past ten days. A total of 106.33M shares are outstanding, with a floating share count of 92.08M. Insiders hold about 13.40% of the company’s shares, while institutions hold 68.89% stake in the company. Shares short for TERN as of 1767139200 were 15452240 with a Short Ratio of 3.76, compared to 1764288000 on 8781897. Therefore, it implies a Short% of Shares Outstanding of 15452240 and a Short% of Float of 14.21.

Earnings Estimates

The firm’s stock currently is rated by 9.0 analysts. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.25 and low estimates of -$0.34.

Analysts are recommending an EPS of between -$1.01 and -$1.2 for the fiscal current year, implying an average EPS of -$1.09. EPS for the following year is -$1.21, with 9.0 analysts recommending between -$0.76 and -$1.54.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.